In addition, there is a considerable amount of evidence demonstrating that GLP-1RAs reduce brain damage in animal models of ischaemic stroke and traumatic brain injury [38,39,54,61,63], and improve the survival of motor neurons in the mutant superoxide dismutase 1 (SOD1; G93A) model of motor neuron disease [50]. The gene discussed is SOD1; the disease is brain injury.